Funding & M&A
Roche Acquires PathAI for $750 Million to Transform AI-Driven Pathology
Roche has agreed to acquire PathAI, the Boston-based digital pathology AI company, for approximately $750 million. The deal combines Roche's global diagnostics infrastructure with PathAI's FDA-cleared AI models for tissue analysis and biomarker identification.
HealthAI Central Editorial Team·May 7, 2026